Fundraising Fox

Kardium

Burnaby · Founded 2013 · Canada (Federal Level) corporation · 5 known investors

Kardium develops the Globe Pulsed Field System, an all-in-one cardiac ablation catheter with 122 individually selectable electrodes that combines high-density mapping and pulsed field ablation. It is designed for physicians treating patients with atrial fibrillation.

Founders & leadership

DGDoug Goertzen
Doug GoertzenExecutive
KCKevin Chaplin
Kevin ChaplinExecutive
AM
Armos MichelsonNamed on SEC filing

Board

MA
Manuel Alba-MarquezBoard director
II
Ian IhnatowyczBoard director
DR
David RosaBoard director

Investors · 5

Reported raises · per SEC filings

Form D private placements

$116.6M disclosed across 2 of 3 rounds · 2014–2025

$116.3MraisedApr 2021 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Manuel Alba-MarquezDirector
  • Ian IhnatowyczDirector
  • David RosaDirector
  • Doug GoertzenExecutive Officer
  • Kevin ChaplinExecutive Officer, Director
Offering amount
$116.3M
Amount sold
$116.3M
Minimum investment
$1
First sale
Dec 2020
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$269.2KraisedApr 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Armos MichelsonDirector
  • Manuel Alba-MarquezDirector
  • Doug GoertzenExecutive Officer, Director
Offering amount
$269.2K
Amount sold
$269.2K
First sale
Mar 2014
Incorporated
Corporation, Canada (federal Level), 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Kardium for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Kardium do?
Kardium develops the Globe Pulsed Field System, an all-in-one cardiac ablation catheter with 122 individually selectable electrodes that combines high-density mapping and pulsed field ablation. It is designed for physicians treating patients with atrial fibrillation.
Who are Kardium's investors?
Kardium's investors include Granada Funds, Eckuity, Fidelity Investments, Janus Henderson Investors, Qatar Investment Authority.
How much funding has Kardium raised?
Kardium has disclosed $116.6M raised across 2 of its 3 known rounds.
Where is Kardium headquartered?
Kardium is headquartered in Burnaby.